Specific induction of CD33 expression by E2A–HLF: the first evidence for aberrant myeloid antigen expression in ALL by a fusion transcription factor
Koshi Akahane(University of Yamanashi), K Sugita(University of Yamanashi), Toshiya Inaba(Hiroshima University), Hidemitsu Kurosawa(St. Jude Children's Research Hospital), Itaru Kuroda(University of Yamanashi), Takeshi Inukai(University of Yamanashi), Hiroaki Goto(Yokohama City University), Makoto Endo(Kyushu University), S Nakazawa(Saitama Children's Medical Center), Nobutaka Kiyokawa(National Center For Child Health and Development), A. Thomas Look(Dana-Farber Cancer Institute), K Hirose(University of Yamanashi), K Kagami(University of Yamanashi), Hiroko Honna(University of Yamanashi), Kumiko Goi(St. Jude Children's Research Hospital), J Fujimoto(National Center For Child Health and Development), Xiaoliu Zhang(University of Yamanashi)
Cited by 14
Related Papers
Acute lymphoblastic leukaemia
|The Lancet|2008|1.6k
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia
|Cancer Cell|2002|1.1k
<i>FBW7</i> mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors
|The Journal of Experimental Medicine|2007|660
Resolution of inflammation by retrograde chemotaxis of neutrophils in transgenic zebrafish
|Journal of Leukocyte Biology|2006|527